drugset / Trial / NCT00517725

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure

NCT00517725 ↗

Phase 4 Completed 60 enrolled Centro Cardiologico Monzino
RandomizedCrossoverSingle-blindTreatment

Summary

The investigators test the hypothesis that different beta-blockers had a different influence on chemoreceptor response and lung diffusion capacity. Both could influence exercise capacity in normoxic as well as hypoxic conditions.

Timeline

Start
2007-07
Primary completion
—
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisoprolol Other / unclassified — —
Comparator Carvedilol Other / unclassified — —
Comparator Nebivolol Other / unclassified — —